Tacrolimus Given As an Alternative to Cyclosporin after Allogeneic HSCT in Case of Renal Impairment: A Prospective Pilot StudyMarie Y. Detrait, Mauricette Michallet, Stéphane Morisset et al.|Blood|2016Cited by 0
Tacrolimus Extended Release could be an Alternative to the use of Cyclosporine after Allogeneic HSCT in case of Renal Impairment due to Cyclosporine: A Prospective pilot study from two centers in FranceMarie Y. Detrait, Fiorenza Barraco, Notarantonio AB et al.|Transplantation Research Journal|2017Cited by 0